Vol 3 (January 2019): Biotarget

Editorial
What’s up with MALAT1?
Gary A. Clawson
Biotarget  
2019;
3:
3  
(25 January 2019) 
PDF Full Text (1566) COI Form Open Access Get Permission
Editorial
The new role of lncRNA MALAT1 as a tumor suppressor
Manuel Regouc, Martin Pichler
Biotarget  
2019;
3:
2  
(23 January 2019) 
PDF Full Text (1545) COI Form Open Access Get Permission
Editorial
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
Brigitte Neuber, Michael Schmitt
Biotarget  
2019;
3:
1  
(09 January 2019) 
PDF Full Text (2190) COI Form Open Access Get Permission